EAI045
Catalog No. A16193
EAI045是一种有效的选择性EGFR抑制剂。EAI045靶向选定的耐药性EGFR突变体,但保留了野生型受体。
Catalog Num | A16193 |
---|---|
M. Wt | 383.4 |
Formula | C19H14FN3O3S |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1942114-09-1 |
Synonyms | EAI-045, EAI 045 |
SMILES | FC1=CC=C(C(C(N2CC(C=CC=C3)=C3C2=O)C(NC4=NC=CS4)=O)=C1)O |
EAI045是一种有效的选择性EGFR抑制剂。EAI045靶向选定的耐药性EGFR突变体,但保留了野生型受体。
Targets
EGFR mutants | ||||
In vitro | DMSO | 75 mg/mL (195.61 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 26.08 mL | 130.41 mL | 260.82 mL |
0.5 mM | 5.22 mL | 26.08 mL | 52.16 mL |
1 mM | 2.61 mL | 13.04 mL | 26.08 mL |
5 mM | 0.52 mL | 2.61 mL | 5.22 mL |
*The above data is based on the productmolecular weight 383.4. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.